Saving eyesight, our most important mission
Use the therapeutic ultrasound technique to fight this chronic eye disease and strive to save the sight of millions of glaucoma patients around the world.
Make ‘focused ultrasound treatment’ an essential step in the management of glaucoma by offering a non-invasive alternative to current treatment options for controlling the intraocular pressure.
Every member of our team works hard to fulfil this goal.
EyeOP1 is the result of many years of joint research between EYE TECH CARE and INSERM (French National Institut of Health and Scientific Research), which led to the innovative use of High Intensity Focused Ultrasound (HIFU) for the treatment of glaucoma patients.
The UCP treatment, which refers to cyclo plasty of the ciliary body, is a simple and fast non-invasive procedure.
Our goal is to make the UCP treatment available for the greatest possible number of glaucoma patients whose previous treatment did not stop the progression of the disease which is seriously threatening their vision.
Company resulting from research
EYE TECH CARE, based in Lyon, France, was founded in 2008 by experts in the field of therapeutic ultrasound, in partnership with INSERM (National Institute of Health and Medical Research)